AG00HYES

15676-16-1 | N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide

AG00HYES

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	15676-16-1
Catalog Number	AG00HYES(AGN-PC-0JK77U)
Chemical Name	N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide
EC Number	239-753-7
IUPAC Name	N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide
InChI	InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)
InChI Key	BGRJTUBHPOOWDU-UHFFFAOYSA-N
MDL Number	MFCD00055061
Molecular Formula	C15H23N3O4S
Molecular Weight	341.4258
SMILES	NS(=O)(=O)C=1C=CC(=C(C(=O)NCC2N(CCC2)CC)C1)OC
Synonyms	Aiglonyl, Arminol, Deponerton, Desisulpid, Digton, Dogmatil, Dolmatil, Eglonyl, Ekilid, Guastil, Lebopride, Meresa, neogama, Pontiride, Psicocen, Sulp, Sulperide, Sulpiride, Sulpitil, Sulpivert, Sulpor, Synédil, Tepavil, Vertigo Meresa, vertigo neogama, Vertigo-Meresa, vertigo-neogama, sulpiride, 15676-16-1, Sulpyrid, Aiglonyl, Dolmatil, Sulpirid, Dogmatil, Dobren, Guastil, (+/-)-Sulpiride, Mirbanil, Misulvan, Sursumid, Abilit, Eglonyl, Meresa, Miradol, Neogama, Omperan, Splotin, Coolspan, Dogmatyl, Psicocen, Pyrkappl, Sernevin, (RS)-(+/-)-sulpiride, Calmoflorine, Alimoral, Championyl, Darleton, Desmenat, Eusulpid, Fardalan, Isnamide, Kylistro, Lisopiride, Mariastel, Norestran, Ozoderpin, Stamonevrol, Sulpirida, Sulpiridum, Sulpitil, Zemorcon, Dresent, Eglonil, Enimon, Equilid, Fidelan, Normum, Nufarol, Omiryl, Restful, Suprium, Valirem, Sulpiridum [INN-Latin], Sulpirida [INN-Spanish], Synedil, N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide, Levosulpiride [INN], Pyrikappl, dl-sulpiride, RD 1403, Levosulpiridum [INN-Latin], Levosulpirida [INN-Spanish], CCRIS 4248, R.D. 1403, Sulpiride [USAN:INN:BAN:JAN], Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-, CHEMBL26, EINECS 239-753-7, N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide, N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide, BRN 0494008, 5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide, C15H23N3O4S, CHEBI:32168, o-Anisamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-, BGRJTUBHPOOWDU-UHFFFAOYSA-N, Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-, MFCD00055061, Levobren, L-Sulpiride, Sulpiride-R, Sulperide, Sulpor, N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoyl-benzamide, (+)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoyl-benzamide, 5-(Aminosufonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, 5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, SMR000038923, SULPIRIDE,(+), SR-01000075402, Sulpride, (y)-Sulpiride, Sulpiride, SLP, (plusmn)-sulpiride, Dogmatyl (TN), Magnetic resonance imaging sulpiride, (?)-Sulpiride, Prestwick_431, (+-)-sulpiride, CAS-15676-16-1, PubChem17241, (.+/-.)-Sulpiride, Prestwick0_000056, Prestwick1_000056, Prestwick2_000056, Prestwick3_000056, SULPIRIDE,(-), Biomol-NT_000037, Biomol-NT_000162, SCHEMBL8421, DSSTox_CID_22574, DSSTox_RID_80050, DSSTox_GSID_42574, Lopac0_001050, Oprea1_602476, BSPBio_000211, (RS)-(A+/-)-Sulpiride, 5-22-08-00105 (Beilstein Handbook Reference), MLS000069434, MLS001306443, DivK1c_000278, SPBio_002132, AC1L1K62, BPBio1_000233, BPBio1_000463, BPBio1_001255, CCRIS-4248, GTPL5501, Sulpiride (JP17/USAN/INN), DTXSID1042574, BDBM11638, CTK8F2082, HMS500N20, KBio1_000278, KS-00000YBQ, Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoyl-, S-(-)-, NINDS_000278, o-ANISAMIDE, N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-5-SULFAMOYL-, (S)-(-)-, Sulpiride 1.0 mg/ml in Methanol, HMS1568K13, HMS2095K13, HMS2231K07, HMS3263A22, HMS3266P12, HMS3371P16, HMS3372O01, HMS3393A08, HMS3651G12, HMS3675D18, HMS3712K13, BCP04500, BCP13871, HY-B1019, ( inverted question mark)-Sulpiride, Tox21_302205, Tox21_501050, s4655, STK368596, AKOS004912732, AN-1017, AN-1019, CCG-205127, CS-4534, DB00391, LP01050, MCULE-7506797476, IDI1_000278, NCGC00015966-03, NCGC00015966-04, NCGC00015966-05, NCGC00015966-06, NCGC00015966-07, NCGC00015966-08, NCGC00024852-02, NCGC00024852-03, NCGC00024852-04, NCGC00024852-05, NCGC00255813-01, NCGC00261735-01, AC-12181, AK163543, LS-20058, LS-20059, AB0105833, EU-0001755, EU-0101050, FT-0652244, R. D. 1403, S0501, D01226, J10067, S 8010, 676S161, L000579, I06-0054, SR-01000075402-2, SR-01000075402-3, SR-01000075402-6, BRD-A55272860-001-03-9, BRD-A55272860-001-04-7, BRD-A55272860-001-08-8, Z84655412, Sulpiride, British Pharmacopoeia (BP) Reference Standard, 1-ethyl-2-(2-methoxy-5-sulfamoylbenzamidomethyl)pyrrolidine, Sulpiride, European Pharmacopoeia (EP) Reference Standard, N-(((S)-1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide, N-(1-Ethyl-pyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoyl-benzamide, N-1-(Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide, (+/-)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide, (+/-)-N-1-(Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide, 5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-benzamide, Benzamide,5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-, (+/-)-5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, (RS)-(+/-)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, 5-(Aminosulfonyl)-N-[(1-ethyl-2- pyrrolidinyl)methyl]-2-methoxy- benzamide, Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-, (S)-, ( inverted question mark)-5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, Levosulpiride, Trilan, Eclorion, Levopraid, Levosulpirida, Levosulpiridum, Deponerton, Desisulpid, Lebopride, Pontiride, Sulpivert, Arminol, Tepavil, Digton, Ekilid, vertigo neogama, vertigo-neogama, Sulp, Vertigo Meresa, Vertigo-Meresa, Compound 7, (??)-Sulpiride, S-(-)-Sulpiride, UNII-7MNE9M8287, CID5355, Sulpiride [USAN:BAN:INN:JAN], 7MNE9M8287, C15-H23-N3-O4-S, CS-O-02320, 23672-07-3, RV-12309, D013469, N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-o-anisamide, Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl- 2-pyrrolidinyl)methyl]-2-methoxy-, o-Anisamide, N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-, (-)-N-(((S)-1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide, (S)-(-)-N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide, Benzamida, 5-(aminosulfonil)-N-[(1-etil-2-pirrolidinil) metil]-2-metoxi-, S-(-)-N-(1-Ethyl-2-pyrrolidinomethyl)-2-methoxy-5-sulfamoylebenzamide,

Complexity	505
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	341.141g/mol
Formal Charge	0
Heavy Atom Count	23
Hydrogen Bond Acceptor Count	6
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	341.426g/mol
Monoisotopic Mass	341.141g/mol
Rotatable Bond Count	6
Topological Polar Surface Area	110A^2
Undefined Atom Stereocenter Count	1
Undefined Bond Stereocenter Count	0
XLogP3	0.6

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H361
Packing Group	Ⅲ
Precautionary statements	P281
UN Code	UN 2811

Certificate of Analysis

Lot Number